Sign Up to like & get
recommendations!
0
Published in 2019 at "ChemMedChem"
DOI: 10.1002/cmdc.201800784
Abstract: Metronidazole is one of the first‐line treatments for non‐severe Clostridium difficile infections (CDI). However, resistance limits its use in cases of severe and complicated CDI. Structure–activity relationships previously described for the 5‐nitroimidazole series have shown…
read more here.
Keywords:
clostridium difficile;
difficile;
nitroimidazoles potent;
potent clostridium ... See more keywords